| Trial ID: | L1018 |
| Source ID: | NCT01063556
|
| Associated Drug: |
Donepezil Hcl
|
| Title: |
Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End-Stage Renal Disease
|
| Interventions: |
DRUG: donepezil HCl|DRUG: donepezil HCl
|
| Outcome Measures: |
Primary: Pharmacokinetics parameter: maximum drug concentration in plasma, 0-48 hours|Pharmacokinetics parameter: maximum drug concentration time in plasma, 0-48 hours|Pharmacokinetics parameter: area under the plasma concentration time curve from Time 0 to 48., 0-48 hours |
|
| Sponsor/Collaborators: |
Sponsor: Eisai Co., Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
6
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2010-02
|
| Completion Date: |
2010-03
|
| Results First Posted: |
|
| Last Update Posted: |
2013-05-14
|
| Locations: |
Moriya, Ibaraki, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT01063556
|
